Last Posted: Jul 05, 2019
- Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
Duruisseaux Michäel et al. The Lancet. Respiratory medicine 2018 6(10) 771-781 - Development of Cancer Immunotherapy
NCI, June 2019 - Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
Dummer Reinhard et al. The Lancet. Oncology 2018 19(10) 1315-1327 - A Rapidly Emerging Field of Cancer Treatment
B Ciupka, NFCR, June 2019 - Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation.
Macher Hada Celicia et al. Clinica chimica acta; international journal of clinical chemistry 2019 Jun - IAPSO-AIRS: A novel improved machine learning-based system for wart disease treatment.
Abdar Moloud et al. Journal of medical systems 2019 Jun 43(7) 220 - Safer CAR T-Cell Therapy
J Abbasi, JAMA, June 11, 2019 - Clinical implications of genetic aberrations in metastatic prostate cancer.
Reichert Zachery R et al. Current opinion in urology 2019 Jul 29(4) 319-325 - The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy.
Low Siew-Kee et al. Japanese journal of clinical oncology 2019 May - New Drugs, New Side Effects: Complications of Cancer Immunotherapy
NCI, May 2019
No comments:
Post a Comment